210 related articles for article (PubMed ID: 19229057)
1. Tumor regrowth between surgery and initiation of adjuvant therapy in patients with newly diagnosed glioblastoma.
Pirzkall A; McGue C; Saraswathy S; Cha S; Liu R; Vandenberg S; Lamborn KR; Berger MS; Chang SM; Nelson SJ
Neuro Oncol; 2009 Dec; 11(6):842-52. PubMed ID: 19229057
[TBL] [Abstract][Full Text] [Related]
2. Patterns of recurrence analysis in newly diagnosed glioblastoma multiforme after three-dimensional conformal radiation therapy with respect to pre-radiation therapy magnetic resonance spectroscopic findings.
Park I; Tamai G; Lee MC; Chuang CF; Chang SM; Berger MS; Nelson SJ; Pirzkall A
Int J Radiat Oncol Biol Phys; 2007 Oct; 69(2):381-9. PubMed ID: 17513061
[TBL] [Abstract][Full Text] [Related]
3. Impact on survival of early tumor growth between surgery and radiotherapy in patients with de novo glioblastoma.
De Barros A; Attal J; Roques M; Nicolau J; Sol JC; Cohen-Jonathan-Moyal E; Roux FE
J Neurooncol; 2019 May; 142(3):489-497. PubMed ID: 30783874
[TBL] [Abstract][Full Text] [Related]
4. Early MRI changes in glioblastoma in the period between surgery and adjuvant therapy.
Farace P; Amelio D; Ricciardi GK; Zoccatelli G; Magon S; Pizzini F; Alessandrini F; Sbarbati A; Amichetti M; Beltramello A
J Neurooncol; 2013 Jan; 111(2):177-85. PubMed ID: 23264191
[TBL] [Abstract][Full Text] [Related]
5. Regional variation in histopathologic features of tumor specimens from treatment-naive glioblastoma correlates with anatomic and physiologic MR Imaging.
Barajas RF; Phillips JJ; Parvataneni R; Molinaro A; Essock-Burns E; Bourne G; Parsa AT; Aghi MK; McDermott MW; Berger MS; Cha S; Chang SM; Nelson SJ
Neuro Oncol; 2012 Jul; 14(7):942-54. PubMed ID: 22711606
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of MR markers that predict survival in patients with newly diagnosed GBM prior to adjuvant therapy.
Saraswathy S; Crawford FW; Lamborn KR; Pirzkall A; Chang S; Cha S; Nelson SJ
J Neurooncol; 2009 Jan; 91(1):69-81. PubMed ID: 18810326
[TBL] [Abstract][Full Text] [Related]
7. 3D MRSI for resected high-grade gliomas before RT: tumor extent according to metabolic activity in relation to MRI.
Pirzkall A; Li X; Oh J; Chang S; Berger MS; Larson DA; Verhey LJ; Dillon WP; Nelson SJ
Int J Radiat Oncol Biol Phys; 2004 May; 59(1):126-37. PubMed ID: 15093908
[TBL] [Abstract][Full Text] [Related]
8. Association of early changes in 1H MRSI parameters with survival for patients with newly diagnosed glioblastoma receiving a multimodality treatment regimen.
Nelson SJ; Kadambi AK; Park I; Li Y; Crane J; Olson M; Molinaro A; Roy R; Butowski N; Cha S; Chang S
Neuro Oncol; 2017 Mar; 19(3):430-439. PubMed ID: 27576874
[TBL] [Abstract][Full Text] [Related]
9. CT and MR imaging after placement of the GliaSite radiation therapy system to treat brain tumor: initial experience.
Matheus MG; Castillo M; Ewend M; Smith JK; Knock L; Cush S; Morris DE
AJNR Am J Neuroradiol; 2004 Aug; 25(7):1211-7. PubMed ID: 15313712
[TBL] [Abstract][Full Text] [Related]
10. Nonenhancing peritumoral hyperintense lesion on diffusion-weighted imaging in glioblastoma: a novel diagnostic and specific prognostic indicator.
Kolakshyapati M; Adhikari RB; Karlowee V; Takayasu T; Nosaka R; Amatya VJ; Takeshima Y; Akiyama Y; Sugiyama K; Kurisu K; Yamasaki F
J Neurosurg; 2018 Mar; 128(3):667-678. PubMed ID: 28362236
[TBL] [Abstract][Full Text] [Related]
11. Utilizing 18F-fluoroethyltyrosine (FET) positron emission tomography (PET) to define suspected nonenhancing tumor for radiation therapy planning of glioblastoma.
Hayes AR; Jayamanne D; Hsiao E; Schembri GP; Bailey DL; Roach PJ; Khasraw M; Newey A; Wheeler HR; Back M
Pract Radiat Oncol; 2018; 8(4):230-238. PubMed ID: 29730279
[TBL] [Abstract][Full Text] [Related]
12. Developing a Pipeline for Multiparametric MRI-Guided Radiation Therapy: Initial Results from a Phase II Clinical Trial in Newly Diagnosed Glioblastoma.
Kim MM; Parmar HA; Aryal MP; Mayo CS; Balter JM; Lawrence TS; Cao Y
Tomography; 2019 Mar; 5(1):118-126. PubMed ID: 30854449
[TBL] [Abstract][Full Text] [Related]
13. Which combination of MR imaging modalities is best for predicting recurrent glioblastoma? Study of diagnostic accuracy and reproducibility.
Kim HS; Goh MJ; Kim N; Choi CG; Kim SJ; Kim JH
Radiology; 2014 Dec; 273(3):831-43. PubMed ID: 24885857
[TBL] [Abstract][Full Text] [Related]
14. Uninterpretable Dynamic Susceptibility Contrast-Enhanced Perfusion MR Images in Patients with Post-Treatment Glioblastomas: Cross-Validation of Alternative Imaging Options.
Heo YJ; Kim HS; Park JE; Choi CG; Kim SJ
PLoS One; 2015; 10(8):e0136380. PubMed ID: 26296086
[TBL] [Abstract][Full Text] [Related]
15. Differentiation between brain tumor recurrence and radiation injury using perfusion, diffusion-weighted imaging and MR spectroscopy.
Bobek-Billewicz B; Stasik-Pres G; Majchrzak H; Zarudzki L
Folia Neuropathol; 2010; 48(2):81-92. PubMed ID: 20602289
[TBL] [Abstract][Full Text] [Related]
16. Relationship of pre-surgery metabolic and physiological MR imaging parameters to survival for patients with untreated GBM.
Crawford FW; Khayal IS; McGue C; Saraswathy S; Pirzkall A; Cha S; Lamborn KR; Chang SM; Berger MS; Nelson SJ
J Neurooncol; 2009 Feb; 91(3):337-51. PubMed ID: 19009235
[TBL] [Abstract][Full Text] [Related]
17. Residual tumor volume versus extent of resection: predictors of survival after surgery for glioblastoma.
Grabowski MM; Recinos PF; Nowacki AS; Schroeder JL; Angelov L; Barnett GH; Vogelbaum MA
J Neurosurg; 2014 Nov; 121(5):1115-23. PubMed ID: 25192475
[TBL] [Abstract][Full Text] [Related]
18. Early tumor growth between initial resection and radiotherapy of glioblastoma: incidence and impact on clinical outcomes.
Villanueva-Meyer JE; Han SJ; Cha S; Butowski NA
J Neurooncol; 2017 Aug; 134(1):213-219. PubMed ID: 28567589
[TBL] [Abstract][Full Text] [Related]
19. Potential value of MR spectroscopic imaging for the radiosurgical management of patients with recurrent high-grade gliomas.
Chuang CF; Chan AA; Larson D; Verhey LJ; McDermott M; Nelson SJ; Pirzkall A
Technol Cancer Res Treat; 2007 Oct; 6(5):375-82. PubMed ID: 17877425
[TBL] [Abstract][Full Text] [Related]
20. [Application of (1)H MR spectroscopic imaging in radiation oncology: choline as a marker for determining the relative probability of tumor progression after radiation of glial brain tumors].
Lichy MP; Bachert P; Hamprecht F; Weber MA; Debus J; Schulz-Ertner D; Schlemmer HP; Kauczor HU
Rofo; 2006 Jun; 178(6):627-33. PubMed ID: 16703499
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
